Mustang Bio
MBIO
81 hedge funds and large institutions have $25.2M invested in Mustang Bio in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 33 reducing their positions, and 12 closing their positions.
209% more call options, than puts
Call options by funds: $68K | Put options by funds: $22K
0.01% less ownership
Funds ownership: 0.04% → 0.03% (-0.01%)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
2% less funds holding
Funds holding: 83 → 81 (-2)
46% less capital invested
Capital invested by funds: $46.4M → $25.2M (-$21.1M)
64% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.38M |
| 2 |
D.E. Shaw & Co
New York
|
+$144K |
| 3 |
TI
Telemetry Investments
New York
|
+$140K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$121K |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$47.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.63M |
| 2 |
Millennium Management
New York
|
-$670K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$308K |
| 4 |
Two Sigma Advisers
New York
|
-$305K |
| 5 |
Two Sigma Investments
New York
|
-$264K |
MBIO Hedge Fund Activity: Q1 2022 in Review
81 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q1 2022, worth a combined $25.2M — down 46% from $46.4M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of MBIO and 11 opened new positions — a net loss of 1 holder — while 33 trimmed existing stakes and 12 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.38M. The largest seller was Vanguard Group, cutting an estimated $1.63M.
- 81 institutional investors held Mustang Bio (MBIO) as of Q1 2022, down from 83 in Q4 2021.
- Funds reported $25.2M of Mustang Bio stock for Q1 2022, down 46% quarter-over-quarter.
- 11 funds opened new Mustang Bio positions in Q1 2022 and 12 closed out, a net change of -1 holder.
- The largest Mustang Bio buyer in Q1 2022 was Renaissance Technologies, an estimated $1.38M added.
- The largest Mustang Bio seller in Q1 2022 was Vanguard Group, an estimated $1.63M sold.
Based on aggregated 13F filings for Q1 2022.